Literature DB >> 21596913

Investigation of carbapenem heteroresistance among different sequence types of Pseudomonas aeruginosa clinical isolates reveals further diversity.

Olga Oikonomou1, Maria Panopoulou2, Alexandros Ikonomidis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21596913     DOI： 10.1099/jmm.0.032276-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  5 in total

1.  Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

Authors:  Sheila Adams-Sapper; Shantell Nolen; Grace Fox Donzelli; Mallika Lal; Kunihiko Chen; Livia Helena Justo da Silva; Beatriz M Moreira; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

Review 2.  Lag Phase Is a Dynamic, Organized, Adaptive, and Evolvable Period That Prepares Bacteria for Cell Division.

Authors:  Robert L Bertrand
Journal:  J Bacteriol       Date:  2019-03-13       Impact factor: 3.490

Review 3.  Mechanisms and clinical relevance of bacterial heteroresistance.

Authors:  Dan I Andersson; Hervé Nicoloff; Karin Hjort
Journal:  Nat Rev Microbiol       Date:  2019-06-24       Impact factor: 60.633

4.  Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt.

Authors:  Mai Mahmoud Zafer; Mohamed Hamed Al-Agamy; Hadir Ahmed El-Mahallawy; Magdy Aly Amin; Seif El Din Ashour
Journal:  BMC Infect Dis       Date:  2015-03-12       Impact factor: 3.090

5.  Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa.

Authors:  Ye Xu; Xiangkuo Zheng; Weiliang Zeng; Tao Chen; Wenli Liao; Jiao Qian; Jie Lin; Cui Zhou; Xuebin Tian; Jianming Cao; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-05-14       Impact factor: 4.003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.